394 related articles for article (PubMed ID: 25308352)
1. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
Love TM; Stohler CS; Zubieta JK
Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
[TBL] [Abstract][Full Text] [Related]
3. Regional brain [(11)C]carfentanil binding following tobacco smoking.
Domino EF; Hirasawa-Fujita M; Ni L; Guthrie SK; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():100-104. PubMed ID: 25598501
[TBL] [Abstract][Full Text] [Related]
4. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
[TBL] [Abstract][Full Text] [Related]
6. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
[TBL] [Abstract][Full Text] [Related]
7. Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum.
Martikainen IK; Nuechterlein EB; Peciña M; Love TM; Cummiford CM; Green CR; Stohler CS; Zubieta JK
J Neurosci; 2015 Jul; 35(27):9957-65. PubMed ID: 26156996
[TBL] [Abstract][Full Text] [Related]
8. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
9. Placebo effects on human mu-opioid activity during pain.
Wager TD; Scott DJ; Zubieta JK
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
11. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
12. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
Yu Z; Wen L; Shen X; Zhang H
Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
[TBL] [Abstract][Full Text] [Related]
13. The human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients.
Menon S; Lea RA; Roy B; Hanna M; Wee S; Haupt LM; Griffiths LR
J Headache Pain; 2012 Oct; 13(7):513-9. PubMed ID: 22752568
[TBL] [Abstract][Full Text] [Related]
14. The A118G single-nucleotide polymorphism of human μ-opioid receptor gene and use of labor analgesia.
Pettersson FD; Grönbladh A; Nyberg F; Sundström-Poromaa I; Åkerud H
Reprod Sci; 2012 Sep; 19(9):962-7. PubMed ID: 22527985
[TBL] [Abstract][Full Text] [Related]
15. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C
Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462
[TBL] [Abstract][Full Text] [Related]
16. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
17. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
[TBL] [Abstract][Full Text] [Related]
18. OPRM1 rs1799971, COMT rs4680, and FAAH rs324420 genes interact with placebo procedures to induce hypoalgesia.
Colloca L; Wang Y; Martinez PE; Chang YC; Ryan KA; Hodgkinson C; Goldman D; Dorsey SG
Pain; 2019 Aug; 160(8):1824-1834. PubMed ID: 31335650
[TBL] [Abstract][Full Text] [Related]
19. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.
Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK
JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634
[TBL] [Abstract][Full Text] [Related]
20. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
Nuechterlein EB; Ni L; Domino EF; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
